# GX Molecular Inc. — Form D

GX Molecular Inc. of CAMBRIDGE, X0, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-20. The offering totals $20.0M, of which $14.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2022-09-20
- Form: D
- Accession: 0001866545-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $14.5M
- Remaining: $5.5M
- Investors: 17
- Date of first sale: 2022-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-459301

## Issuer

- Name: GX Molecular Inc.
- CIK: 0001866545
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: WEWORK 50-60 STATION ROAD, CAMBRIDGE, X0, CB1 2JH
- Phone: 44 0 784 588 9519

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| LUCAS EDELMAN | Director | CAMBRIDGE, X0 |
| LUCAS EDELMAN | Executive Officer | CAMBRIDGE, X0 |
| JEREMY DICKINSON PRESTON | Executive Officer | CAMBRIDGE, X0 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-06-10](https://search.stillhousedata.com/formd/0001866545-21-000001) | D | $2.2M | $2.2M |

## More

- [CIK 1866545 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1866545&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001866545-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.